HCONRES 380
107th Congress
House
Health
Access to health care
Blood diseases
Child health
Congress
Congressional reporting requirements
Genetic counseling
Genetic screening
Health education
Hemophilia
Hormone replacement therapy
Hysterectomy
Medical research
Medical screening
Medical tests
Menstruation
Preventive medicine
Science, Technology, Communications
Women's health
Expressing the sense of the Congress regarding women with bleeding disorders.
Introduced: April 17, 2002
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 23, 2002
Referred to the Subcommittee on Health.
Apr 17, 2002
Referred to the House Committee on Energy and Commerce.
Apr 17, 2002
Introduced in House
Plain-English summary
Expresses the sense of Congress that (1) physicians should screen all adolescents and all adult women presenting with severe menorrhagia for von Willebrand's disease; (2) hysterectomy for excessive menstrual bleeding should not be performed without the consideration of a bleeding disorder; (3) referral of women with bleeding disorders to a federally sponsored hemophilia treatment center is critical to comprehensive treatment; (4) physicians should be encouraged to conduct clotting factor assays for carrier diagnosis and to facilitate genotyping of the disorder and patients should be referred for genetic counseling when appropriate; (5) patient advocate organizations and medical specialty societies should continue to collaborate on public education campaigns to educate women about bleeding disorders; (6) the Federal Government has a responsibility to further research on von Willebrand's disease and improve access to hemophilia treatment centers for all individuals with bleeding disorders; (7) the Director of the National Institutes of Health should develop a 5-year research plan concerning women with bleeding disorders; and (8) the Director of the Centers for Disease Control and Prevention should continue to improve outreach, treatment, and prevention of the complications of women's bleeding disorders.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2